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Purpose: To evaluate the effectiveness of new management policies on the incidence of invasive 
Candida infections
Methods: This observational study involved a retrospective analysis of the patients’ medical records. 
In total, 99 very low birth weight infants, who were admitted to the neonatal intensive care unit at Ajou 
University Hospital from January 2010 to December 2011, were enrolled for the study. Period I, defined 
as the period before the revision of management policies, comprised 57 infants; whereas, period II, 
defined as the period after the implementation of new management policies, comprised 42 infants. The 
new management policies entailed a reduction in antibiotic and histamine type 2 receptor blocker (H2 
blocker) use, duration of central venous catheterization, and duration of endotracheal intubation.
Results: There was a significant overall decrease in the use of antibiotics including 3rd generation 
cephalosporin and H2 blockers (P<0.05), and a significantly lower incidence of invasive Candida 
infections in period II as compared to period I (0/42 vs. 6/57, respectively; P=0.037). Comparison 
between infants with invasive Candida infections (n=6) and those without (n=93) showed that 
gestational age (odds ratio [OR], 0.909; 95% confidence interval [CI], 0.829 to 0.996; P=0.042) and 
the duration of 3rd generation cephalosporin use (OR, 1.093; 95% CI, 1.009 to 1.183;  P=0.029) were 
statistically significant risk factors.
Conclusion: The new management policies effectively decreased overall use of antibiotics, especially 
3rd generation cephalosporin, and H2 blockers, which led to a significantly lower incidence of invasive 
Candida infections. 
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Introduction
Despite recent advances in neonatal intensive care and an increase in survival of very 
preterm infants, sepsis due to nosocomial infection has been a common problem that 
result in significant morbidity and mortality
1,2).
Fungi are the third most frequent etiologic organisms of late onset sepsis in preterm 
infants
3,4), with an incidence of 1.6% to 3% in a very low birth weight (VLBW) infants, 
and up to 15% to 20% in extremely low birth weight (ELBW) infants
4-6) and mortality 
ranges from 25% to 55%
1,6). Invasive fungal infection in the neonatal period is associated 
with early gestational age, low birth weight, central venous catheterization, mechanical 
ventilation, use of broad spectrum antibiotics, especially the 3rd generation cephalosporin, 
delayed enteral feeding and the use of histamine type 2 receptor blocker (H2 blocker)
5,7). 69 http://dx.doi.org/10.3345/kjp.2013.56.2.68
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However, there have been only few studies that deal with the 
effect of clinical interventions on risk factors in a neonatal 
intensive care unit (NICU) setting.
Invasive Candida infection is an important and critical 
problem that is often encountered in our NICU. Therefore, 
authors re  viewed the overall management policies that is 
associated with nosocomial infection in our NICU, and revised it 
in order to prevent invasive Candida infection.
This study was done to compare the management and out-
comes that are associated with invasive Candida infection 
and overall nosocomial sepsis before and after revising the 
management policies, and thus, evaluate the effectiveness of the 
new management policies.
Materials and methods
1. Study design and setting
This study was an observational study, which incorporated the 
reviewing of medical records in a retrospective manner. Among 
the 108 VLBW infants admitted to the NICU, at the Ajou University 
Hospital from January 2010 to December 2011, a total of 99 
VLBW infants were enrolled in this study. Of those, 57 infants 
born from January 2010 to December 2010 were included in 
period I (before revising management policies), and 42 infants 
born from January 2011 to December 2011 were included in 
period II (after revising management policies). Nine infants were 
excluded in this study; six infants in period I were excluded due 
to deaths within the postnatal one week (n=4) and temporal 
overlap with period II (n=2). Three infants in period II were 
excluded due to deaths within postnatal one week (Fig. 1). 
Demographic data were collected, including the gestational 
age, birth weight, hospital days, gender, Apgar score (1 minute, 5 
minutes) and the use of surfactant and indomethacin. This study 
was approved by the Institutional Review Board at the Ajou 
University Hospital.
After reviewing the medical records of infants admitted to 
the NICU in 2010 and the associated studies, we revised the 
management policies as follows.
1) Reduction in the use of antibiotics, especially the 3rd 
generation cephalosporin
Initial empirical antibiotics used in period I were ampicillin 
plus cephalosporin and in period II, ampicillin plus gentamicin 
8). 
Administration of extended period of antibiotics was sup pressed 
by early discontinuation of antibiotics after considering laboratory 
results and symptom changes on 3rd and 7th day of treatment
9). 
Vancomycin was prescribed only in symptomatic infants with 
confirmed methicillin resistant Staphylococci growth in culture 
studies
10). Use of carbapenem without evidence of necrotizing 
enterocolitis (NEC, >stage Ib) or multidrug resistant bacteria was 
suppressed
11).
2) Reduction in the use of H2 blocker
In period I, H2 blocker was used when more than 3 days of 
fasting was required in infants. However in period II, H2 blocker was 
administrated only in infants who had a risk of stress-related 
mucosal damage that can occur rapidly, including con ditions 
such as sepsis or after surgery
12). 
3) Reduction in the duration of central venous catheterization 
and endotracheal intubation
This was achieved by encouraging early enteral feeding and 
disuse of invasive mechanical ventilation by early weaning and 
removal of endotracheal tube. 
Through this study, authors tried to compare the management 
and outcomes associated with an invasive Candida infection 
and the overall nosocomial sepsis before and after the revision 
of management policies, and evaluate the effectiveness of new 
management policies, regarding invasive Candida infections.
2. Definitions and blood culture method
Nosocomial sepsis was defined on the basis of Center for 
Disease Control and Prevention criteria
13). Even when a positive 
blood culture was identified in our hospital microbiology labo-
ratory with automated BACTEC system, the infant’s systemic 
instability such as apnea, bradycardia and feeding intolerance, 
and laboratory values such as C-reactive protein at the time of 
sampling, was considered to exclude possible contamination and 
colonization. Only when such systemic instability and increase 
in C-reactive protein was accompanied with positive blood 
Fig. 1. Selection and exclusion of study patients. ELBW, extremely low 
birth weight; Bwt, birth weight.http://dx.doi.org/10.3345/kjp.2013.56.2.68
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cultures or when the same bacteria or fungus was recultured, it 
was defined as true sepsis
11,14). 
Bronchopulmonary dysplasia was defined as when there is 
a need for supplemental oxygen support at the 36 weeks’ post-
menstrual age
15), and the NEC was defined as the Bell’s stage 
II or greater
16) and stage III or IV intraventricular hemorrhage 
as Papile’s classification
17). Full enteral feeding was defined as 
feeding of more than 100 kcal/kg/day.
3. Statistical analysis
Categorical data are presented as numbers (%), and continuous 
data as the mean±standard deviation or the median (25—75%). 
The χ
2 or Fisher’s exact test was used to compare the categorical 
variables and the Student’s t-test, paired t-test, Mann-Whitney’s 
rank sum U test were also used. Data were analyzed using IBM 
SPSS ver. 19.0 (IBM Co., Armonk, NY, USA). A P value of <0.05 
was considered significant. Multiple logistic regression with 
forward conditional variable selection was performed with the 
risk factors identified as significant in the univariate analysis.
Results
1. Summary of nosocomial sepsis in period I and II
There were a total of 15 infants with nosocomial sepsis in 
period I (26%, 15/57). Of these, 6 of them had invasive Candida 
infections in whole blood cultures. Candida infection was 
found on average of 26.8 days of birth (range, 11 to 50 days). 
Liposomal amphotericin B (5 mg/kg/dose) was administrated 
on average of 19.3 days. Three of the treated infants expired 
and in one case, voriconazole was used due to treatment failure 
with liposomal amphotericin B. There were 7 infants with gram-
positive cocci sepsis and 3 infants with gram-negative bacilli 
sepsis with proven Klebsiella oxytoca and Enterobacter cloacae 
growths. One infant had experienced two episodes of nosocomial 
sepsis with Candida and gram-positive coccus, respectively. 
In period II, there were 6 infants with nosocomial sepsis (14%, 
6/42). There were no invasive Candida infections in period II. Out 
of these 6 infants, 5 infants had gram-positive cocci sepsis, all 
with proven Staphylococcus epidermidis growth, and one infant 
had gram-negative bacilli sepsis with proven Pseudomonas 
aeruginosa growth. All the cultured S. epidermidis in period I 
and period II were methicillin resistant S. epidermidis. Sum mary 
of comparison of nosocomial sepsis in period I and II are shown 
in Table 1. 
2. Comparisons of demographic data between period I and period II
There were no significant differences in the gestational age, birth 
weight and hospital days between the period I and II. Total number 
of infants admitted to the NICU in period I and II were 755 and 
725, respectively. Total inpatients service day for period I and II 
were 8,159 and 8,092, respectively, and there were no statistical 
significant difference between these two periods. There were 
no changes in the members of the nursing team. Guidelines for 
hand-washing, infant handling and central venous catheter 
management were constantly regulated and maintained. The 
demographic data of these two groups are shown in Table 2.
3. Comparisons of morbidity and mortality between period I 
and period II
Although most of the perinatal morbidities and mortality 
were not different between the two periods, incidence of NEC 
decreased significantly in period II, in comparison to period I 
(period I, 16% [9/57] vs. period II, 2.3% [1/42]; P=0.041). The 
demographic data of these two groups are shown in Table 3.
4. Comparisons of incidence of sepsis and associated factors 
between period I and period II 
The use of the overall antibiotics (period I, 41±28 vs. period 
Table 1. Summary of cases diagnosed with sepsis in period I and II
Period Case no. GA (wk) Bwt (g) Cultured microorgnism
I (15/57) 1 25
+5 880 C. parapsilosis
2* 24
+2 720 C. albicans
3* 24
+0 560 C. parapsilosis
4 24
+5 770 C. guilliermondii
5* 26
+0 830 S. epidermidis
6 24
+2 750 S. epidermidis
7* 24
+2 710 C. guilliermondii
8 29
+3 1,220 K. oxytoca
9 33
+3 1,120 E. cloacae
10* 29
+0 1,260 E. colacae
11 28
+4 1,390 C. albicans
12 28
+6 1,440 S. epidermidis
13 25
+3 770 S. epidermidis
14 29
+6 930 S. epidermidis
15 29
+0 1,320 S. aureus
II (6/42) 1 27
+0 890 S. epidermidis
2 29
+2 910 S. epidermidis
3 24
+0 810 S. epidermidis
4 25
+6 620 P. aeruginosa
5 26
+3 920 S. epidermidis
6 27
+0 1,030 S. epidermidis
GA, gestational age; Bwt, birth weight; C. parapsilosis, Candida parapsilosis; 
C. albicans, Candida albicans; C. guilliermondii, Candida guilliermondii; S. 
epidermidis, Staphylococcus epidermidis; K. oxytoca, Klebsiella oxytoca; 
E. cloacae, Enterobacter cloacae; S. aureus, Staphylococcus aureus; P. 
aeruginosa, Pseudomonas aeruginosa.
*Expired case.71 http://dx.doi.org/10.3345/kjp.2013.56.2.68
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II, 23±20; P<0.001) and the 3rd generation cephalosporin (period I, 
12±13 vs. period II, 5±7; P=0.002) decreased in period II when 
compared to period I. Although the use of vancomycin was 
not different between the two periods, the use of carbapenem 
increased in period II, compared to that of period I. The use of H2 
blockers were decreased in period II compared to period I (period 
I, 19±21 vs. period II, 5±7; P<0.001). The duration of the central 
venous catheterization, total parenteral nutrition (TPN) and 
invasive mechanical ventilation were not significantly different 
between the two periods. Also, the use of systemic steroid and 
the day of the first enteral feeding and the full enteral feeding 
were not significantly different between the two periods (Table 
4). Although the incidences of overall no  socomial, gram-positive 
cocci and gram-negative bacilli sepsis were not statistically 
different between the two periods, the incidence of invasive 
Candida infection exhibited a significant decrease in period II, in 
comparison to that of period I (period I, 11% [6/57] vs. period II, 
0% [0/42]; P=0.037) (Table 5). 
5. Risk factor associated with invasive Candida infection
In the univariate analysis, infants with invasive Candida 
infec  tion (n=6) compared to infants without invasive Candida 
nfection (n=93), showed lower birth weight, younger gesta-
tional age, longer use of overall antibiotics including 3rd gene-
ration cephalosporin, longer use of H2 blocker and longer duration 
of endotracheal intubation (P<0.05). Multiple logistic regression 
with identified significant risk factors in the univariate analysis 
showed that the gestational age (odds ratio [OR], 0.909; 95% 
confidence interval [CI], 0.829 to 0.996; P=0.042) and the use of 
3rd generation cephalosporin (OR, 1.093; 95% CI, 1.009 to 1.183; 
P=0.029) were statistically significant.
Discussion
The incidence of invasive fungal infection is known to be 1.6— 
3% in VLBW and 15—20% in ELBW infants
4-6). Candida species 
are the most common fungal pathogens
18) and comprise 70— 
90% of all invasive fungal infections in neonates
19). Neo nates 
themselves are known to be a risk factor for Candida infections, 
Table 2. Comparison of demographic data between period I and period II
Period I (n=57) Period II (n=42) P value
GA (wk) 29±0 28±4 0.518
Bwt (g) 1,156±257 1,109±244 0.367
Hospital days 56±29 66±38 0.162
Apgar score (1 min) 3 (2—4) 3 (2—5) 0.366
Apgar score (5 min) 4 (3—6) 5 (3—6) 0.506
Male sex 30/57 (53) 20/42 (48) 0.622
Use of surfactant 46/57 (81) 32/42 (76) 0.625
Use of indomethacin 5/57 (9) 3/42 (7) 1.000
Values are presented as mean±standard deviation, median (range) or number 
(%).
GA, gestational age; Bwt, birth weight.
Table 3. Comparison of morbidity and mortality rates between period I 
and period II
Period I (n=57) Period II (n=42) P value
Ligation of PDA 16/57 (29) 11/42 (26) 0.836
BPD 28/57 (49) 15/42 (36) 0.183
NEC (>stage Ib)* 9/57 (16) 1/42 (2.3) 0.041
IVH (>stage II) 4/57 (7) 3/42 (7) 1.000
Laser operation for ROP 3/57 (5) 5/42 (12) 0.278
Mortality 8/57 (14) 1/42 (2) 0.074
Values are presented as number (%).
PDA, patent ductus arteriosus; BPD, bronchopulmnary dysplasia; NEC, necroti  zing 
enterocolitis; IVH, intraventricular hemorrhage; ROP, retinopathy of prematurity.
*P<0.05.
Table 4. Comparison of factors associated with sepsis between period I 
and period II
Period I (n=57) Period II (n=42) P value
Use of antibiotics (day)* 41±28 23±20 0.000
Use of the 3rd generation 
 cephalosporin (day)*
12±13 5±7 0.002
Use of vancomycin (day) 2±4 4±6 0.095
Use of carbapenem (day)* 0.2±1 1±3 0.028
Duration of PCVC (day) 29±24 33±26 0.458
Duration of UVC (day) 1±2 1±2 0.297
Duration of TPN (day) 26±28 27±22 0.830
Frequency of transfusion 4±4 4±4 0.686
Use of H2 blocker (day)* 19±21 5±7 0.000
Day of first enteral feeding  9±12 8±8 0.507
Day of full enteral feeding 37±26 31±20 0.191
Duration of endotracheal 
 intubation (day)
18±23 18±22 0.960
Systemic steroids 13/57 (23) 7/42 (17) 0.613
Values are presented as mean±standard deviation or number (%).
PCVC, percutaneous central venous catheterization; UVC, umbilical vein 
catheterization, TPN, total parenteral nutrition, H2 blocker, histamine type 2 
receptor blocker. 
*P<0.05
Table 5. Comparison of sepsis incidence between period I and period II
Period I (n=57) Period II (n=42) P value
Sepsis 15/57 (26)   6/42 (14) 0.148
Invasive Candida infection*   6/57 (11) 0/42 (0) 0.037
Sepsis of gram (+) cocci   7/57 (12)   5/42 (12) 0.797
Sepsis of gram (-) bacilli 3/57 (5) 1/42 (2) 0.635
Values are presented as number (%).
*P<0.05.http://dx.doi.org/10.3345/kjp.2013.56.2.68
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along with immune-compromised children, such as recipients 
of organ transplantations and children in the intensive care 
units
20). In addition, lower birth weight, use of cephalosporin, 
difference in gender and lack of enteral feeding are associated 
with Candida infections in the neonatal period
21). Particularly, 
VLBW infants are reported to have 25—35 times greater risk 
for invasive Candida infection when compared to the full term 
infants
22). Recently, many studies have been reported on the 
use of fluconazole prophylaxis for the preven tion of invasive 
fungal infection
23-25) and fluconazole pro phylaxis seems to 
inhibit the fungal colonization in the skin, gastrointestinal 
tract and respiratory tract
26). However, routine prophylaxis with 
fluconazole is not recommended in all new borns
27). Therefore, 
fluconazole prophylaxis should be used selectively in high risk 
preterm infants with additional risk factors, such as central 
venous catheterization and extended period of exposure to broad 
spectrum antibiotics
28).
For the prevention of invasive Candida infection in our 
NICU, 1) reduction in the use of antibiotics, especially the 3rd 
generation cephalosporin, 2) reduction in the use of H2 blockers, 
3) reduction in the duration of central venous ca theterization 
by encouraging enteral feeding and invasive mechanical 
ventilation by early removal of endotracheal tube were done. 
Routine fluconazole prophylaxis was not applied. Significant 
decrease in the use of the 3rd generation cephalosporin and H2 
blockers were achieved. To reduce the use of 3rd generation 
cephalosporins, its administration was limited to infants 
with meningitis or with proven blood cultures only. Follow-
up blood cultures and laboratory tests including C-reactive 
protein, complete blood count and differential count were done 
on 3rd and 7th day of administra tion of antibiotics for the 
early detection of improvement of infant’s status. Results were 
interpreted for making decision for early discontinuation of 
antibiotics. However, compared to that of period I, the duration 
of central venous catheteriation and endotracheal intubation 
was not reduced in period II. In addition, compared to period I, 
day of the first enteral feeding and full enteral feeding was not 
achieved any earlier in period II. There were also no difference 
between the two groups on the duration of TPN, frequency of 
transfusions and use of systemic steroids. These results might be 
due to the improved survival rate of ELBW infants in period II, 
although, there was no statistical significance. 
Authors observed a decreased incidence of NEC in period II, 
compared to that of period I, and it is thought to be due to reduced 
use of antibiotics. Antibiotic use in the neonatal pop ulation has 
been previously described as a potential contributing factor in 
the development of NEC. Multivariate analyses aimed to exclude 
confounding factors, such as gestational age, birth weight and 
sepsis have shown similar persistent results
29,30). Such antibiotic 
administration may result in suppression or eradication of 
protective anaerobic bacteria which normally colonize the 
gastrointestinal tract and thereby result in over growth of potentially 
pathogenic enteric aerobic gram-negative rods
31,32). Combined with 
the impairment in the intestinal barrier, colonization of pathogenic 
bacteria superior to that of the normal flora may predispose 
preterm infants to NEC
33).
Despite the fact that new management policies of our unit 
did not include fluconazole prophylaxis, the new policies 
nevertheless succeeded in reducing the use of H2 blockers, and 
overall use of antibiotics, especially the 3rd generation ceph-
alosporin, and thereby successfully decreased the invasive 
Candida infection in our unit. As shown in the table, out of total 
75 VLBW infants in period I, 6 had invasive Candida infection 
(10.5%, 6/57) and all of them were treated with liposomal 
amphotericin B (5 mg/kg). First line antifungal agent commonly 
used in our hospital is amphotericin B or fluconazole. However, 
we have chosen liposomal amphotericin B because among 
the 6 infants with invasive Candida infection, 2 had initial 
renal insufficiency and 4 showed oliguria progressing to renal 
insufficiency
34).
There were 6 (20%) invasive Candida infection out of 30 VLBW 
infants in 2008, and 4 out of 34 (11.7%) in 2009, showing a 
consistent invasive Candida infection every year. These incidence 
rates are similar compared to the previously reported incidence rates 
in the literature. Invasive Candida infection were not in the form of 
outbreaks, but rather in sporadic manner with many various strains 
of Candida, including Candida parapsilosis, Candida albicans and 
Candida guilliermondii. However, after policy modification and 
application, there was not one case of invasive Candida infection in 
period II.
In the univariate analysis comparing the infants with and 
without invasive Candida infection, lower birth weight, younger 
gestational age, longer use of overall antibiotics, including 3rd 
generation cephalosporin, longer use of H2 blocker and longer 
duration of invasive mechanical ventilation were statistically 
significant risk factors. However, after multiple logistic regres-
sion, gestational age and use of 3rd generation cephalo sporin 
were the only significant risk factors.
This study, therefore, shows that strict establishment and 
refreshment of clinical policies in the NICU can control invasive 
Candida infection in VLBW infants with critical conditions and 
additional risk factors. However, sepsis of gram-positive cocci 
has often occurred in our NICU in both periods I and II. More 
careful control in the insertion and the maintenance of central 
venous catheter may be needed to control such infec tions in our 
NICU. 
Most of the published data are retrospective comparative 
analysis of infants with or without invasive fungal infection. 
Manzoni et al.
6) has showed that independent risk factors for 
invasive fungal infection are colonization of the central venous 73 http://dx.doi.org/10.3345/kjp.2013.56.2.68
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catheter and colonization in multiple sites, and Saiman et al.
5) 
reported that gestational age <32 weeks, 5-minute Apgar <5, 
shock, disseminated intravascular coagulopathy, prior use of 
Intralipid, parenteral nutrition, central venous catheters, H2 
blockers, intubation or length of stay >7 days before candidemia 
were all factors related to invasive fungal infection. Kaufman 
35) showed that a decrease in the use of the 3rd and 4th generation 
cephalosporin and carbapenem class broad-spectrum antibiotics, 
H2 blocker and proton pump inhibitors, and steroids, such as 
dexamethasone, could lower the incidence of invasive fungal 
infection. Early trophic feeding, typically within 3 days of birth, and 
breast feeding could also contribute to the prevention of invasive 
fungal infection
35) .
A study that changed the variety of parameters and mana-
gement policies, along with investigating its efficacy and 
outcome, somewhat similar to our study, was done by Hwang et 
al.
36). In that study, the restriction of antibiotic therapy, less use 
of invasive procedures, such as umbilical vein catheterization 
and endotracheal intubation, establishment of guidelines for 
hand-washing, infant handling, and central intravascular line 
management significantly decreased the nosocomial infection 
in ELBW infants. Only the duration of antibiotics treatment was an 
independent risk factor for nosocomial infection.
The duration and follow-up of our study is somewhat short 
and the number of subjects is limited. Also, this study was done 
retrospectively. For a more objective result, there may be a need for 
a prospective study with a large number of subjects. Nonetheless, 
it is proven that decrease in the use of the 3rd generation 
cephalosporin in a single unit effectively lowers the incidence of 
invasive Candida infection. It is also a significant finding that with 
just preventive policies and without routine use of prophylactic 
fluconazole, invasive Candida infection can be reduced to less than 
reported rates. To maintain such low incidence rates, efforts must 
be put into decreasing the duration of ventilator care and central 
venous catheter insertion period, and to start early feeding, along 
with decreasing the use of the 3rd generation cephalosporin and H2 
blockers.
In conclusion, new management policies in our NICU resulted 
in a reduction of the overall use of antibiotics, especially the 
3rd generation cephalosporin, and H2 blockers. Furthermore, 
reduction in the use of 3rd generation cephalosporin had a sig-
nificant effect on decreasing the incidence of invasive Candida 
infection in our NICU.
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